ESC 365 - Panel discussion and closing remarks - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

EHRA Premium Access

Panel discussion and closing remarks - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Session: Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Topic: Oral Anticoagulation

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Sponsored by Daiichi Sankyo, Europe

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

30 presentations

1 follower

4 more presentations in this session

Welcome and Introduction - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Speaker: Professor S. Hohnloser (Frankfurt, DE)

ELIMINATE-AF trial in the context of other non-vitamin K antagonist oral anticoagulant trials.

Speaker: Professor J. Kautzner (Prague, CZ)

Implications of non-vitamin K antagonist oral anticoagulant trials in ablation practice.

Speaker: Doctor M. Grimaldi (Acquaviva Delle Fonti, IT)

Current recommendation for atrial fibrillation patients undergoing ablation.

Speaker: Professor J. Steffel (Zurich, CH)

Access the full session

Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Speakers: Professor S. Hohnloser, Professor S. Hohnloser, Professor J. Kautzner, Doctor M. Grimaldi, Professor J. Steffel

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources